Autobacs Seven Co (9832) AI Stock Analysis

• Market Cap: ¥128.67B
• Dividend Yield: 3.63%
• Average Volume (3M): 167.22K
• Price to Earnings (P/E): 13.9
• Beta (1Y): 0.41
• Revenue Growth: 17.43%
• EPS Growth: 248.12%
• Country: JP
• Employees: 4,385
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Specialty Retail
• EPS (TTM): 66.43
• Shares Outstanding: 82,050,100
• 10 Day Avg. Volume: 173,620
• 30 Day Avg. Volume: 167,220
• PEG Ratio: 0.53
• Price to Book (P/B): 0.90
• Price to Sales (P/S): 0.47
• P/FCF Ratio: -23.71
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 75 Outperform
• Price Target: ¥1,776.00 ▲(13.05% Upside)

Autobacs Seven Co's overall stock score reflects strong financial performance and positive technical indicators. The stock is reasonably valued with an attractive dividend yield. However, concerns about cash flow generation and liquidity slightly temper the overall score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a strong market position and effective business strategies, supporting long-term sustainability.

Balance Sheet Health

A strong balance sheet with low leverage enhances financial stability and provides flexibility for future investments and growth.

Profitability Improvement

Improved profitability margins reflect efficient cost management and pricing strategies, contributing to sustainable earnings growth.

Negative Factors

Cash Flow Constraints

Decreased cash flow from operations can limit the company's ability to fund new projects and manage operational needs, posing a risk to long-term growth.

Negative Free Cash Flow

Negative free cash flow suggests challenges in generating sufficient cash to cover capital expenditures, affecting future investment capacity.

Operational Efficiency

Lower operational margins indicate potential inefficiencies, which could hinder profitability if not addressed, impacting competitive positioning.

Autobacs Seven Co Business Overview & Revenue Model

Company Description

Autobacs Seven Co. (9832) is a leading Japanese retailer specializing in automotive parts, accessories, and services. Founded in 1947, the company operates a chain of stores under the Autobacs brand, offering a wide range of products including tires, batteries, car audio systems, and maintenance services. In addition to retail operations, Autobacs engages in online sales and provides various automotive-related services, catering to both individual consumers and businesses in the automotive sector.

How the Company Makes Money

Autobacs Seven Co. primarily generates revenue through the sale of automotive parts and accessories in its retail stores and online platforms. Key revenue streams include product sales from their extensive inventory of automotive supplies, tire services, and vehicle maintenance offerings. The company also earns income from service contracts and memberships that provide customers with discounts and exclusive offers. Additionally, Autobacs benefits from strategic partnerships with manufacturers and suppliers, which enhance their product offerings and can lead to favorable pricing. The company may also generate revenue through franchise operations, allowing other retailers to operate under the Autobacs brand, thus expanding its market presence and revenue base.

Autobacs Seven Co Financial Statement Overview

Summary

Autobacs Seven Co shows strong revenue and profit growth with a robust balance sheet. However, the decline in cash flow generation raises concerns about liquidity and operational cash management.

Income Statement

Autobacs Seven Co has demonstrated strong revenue growth, with a Revenue Growth Rate of 8.55% from 2024 to 2025. The Gross Profit Margin improved to 35.42%, and the Net Profit Margin increased to 3.26% in 2025, reflecting enhanced profitability. However, the EBIT Margin at 4.86% and EBITDA Margin at 7.67% suggest room for operational efficiency improvements.

Balance Sheet

The company maintains a stable financial position with a Debt-to-Equity Ratio of 0.29, indicating conservative leverage. The Return on Equity is healthy at 6.17%, showing effective use of shareholder funds. The Equity Ratio of 57.76% affirms a strong equity base, but there is a slight increase in total debt, which may require monitoring.

Cash Flow

Cash flow from operations decreased significantly, impacting the company's liquidity position. The Operating Cash Flow to Net Income Ratio dropped to 0.48, and Free Cash Flow turned negative at -4982 million, indicating potential cash constraints. The Free Cash Flow to Net Income Ratio is also negative, which is a concern for future investments.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	259.74B	249.53B	229.86B	236.24B	228.59B	220.45B
Gross Profit	92.86B	88.37B	75.42B	79.46B	77.15B	73.29B
EBITDA	21.66B	19.14B	15.66B	16.41B	15.64B	14.73B
Net Income	9.40B	8.13B	6.36B	7.24B	7.01B	7.05B
Balance Sheet
Total Assets	223.23B	228.17B	194.95B	194.33B	189.91B	187.91B
Cash, Cash Equivalents and Short-Term Investments	31.13B	31.29B	31.30B	24.57B	24.80B	38.94B
Total Debt	34.56B	37.82B	9.32B	12.19B	10.76B	12.66B
Total Liabilities	91.43B	96.20B	65.80B	67.37B	67.02B	64.08B
Stockholders Equity	131.41B	131.81B	128.84B	126.62B	122.55B	123.18B
Cash Flow
Free Cash Flow	0.00	-4.98B	5.28B	3.50B	-588.00M	13.17B
Operating Cash Flow	0.00	3.94B	14.43B	10.69B	5.71B	17.16B
Investing Cash Flow	0.00	-18.02B	-449.00M	-7.65B	-7.71B	-6.08B
Financing Cash Flow	0.00	13.97B	-7.41B	-3.50B	-12.30B	-309.00M

Autobacs Seven Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1571.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9832, the sentiment is Positive. The current price of 1571 is below the 20-day moving average (MA) of 1648.05, below the 50-day MA of 1639.30, and above the 200-day MA of 1526.18, indicating a bullish trend. The MACD of 0.50 indicates Positive momentum. The RSI at 52.37 is Neutral, neither overbought nor oversold. The STOCH value of 42.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9832.

Autobacs Seven Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9832	75 Outperform	¥128.67B	13.93	7.75%	3.63%	17.43%	248.12%
7419	74 Outperform	¥326.05B	7.99	―	1.35%	15.92%	52.76%
2666	67 Neutral	¥2.51B	8.21	―	1.92%	11.96%	30.75%
8282	67 Neutral	¥253.32B	23.15	―	2.72%	2.23%	57.10%
3048	66 Neutral	¥296.49B	15.60	11.17%	2.61%	5.63%	25.64%
9831	64 Neutral	¥455.72B	14.08	4.18%	2.57%	1.26%	14.65%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%

Autobacs Seven Co Corporate Events

Autobacs Seven Posts Double-Digit Profit Growth and Keeps Full-Year Forecast, Dividend Plan Intact

Autobacs Seven reported strong consolidated results for the nine months ended 31 December 2025, with net sales rising 12.6% year on year to ¥211.96 billion, operating profit up 25.2% to ¥12.45 billion, and profit attributable to owners of parent increasing 14.1% to ¥8.72 billion, lifting basic earnings per share to ¥111.02. The company’s total assets expanded to ¥269.68 billion and net assets to ¥137.43 billion, although the equity ratio declined to 50.8%, and management kept its full-year forecast unchanged, targeting ¥276.0 billion in net sales and ¥8.2 billion in profit attributable to owners of parent, alongside maintaining an annual dividend forecast of ¥60 per share, signaling confidence in earnings stability and continued shareholder returns.

The most recent analyst rating on (JP:9832) stock is a Buy with a Yen1816.00 price target. To see the full list of analyst forecasts on Autobacs Seven Co stock, see the JP:9832 Stock Forecast page.

Autobacs Seven December Sales Slip on Weak Winter Goods, Services Stay Strong

Autobacs Seven reported that in December 2025 its domestic same-store sales fell 4.4% year on year, while total-store sales declined 3.5%, reflecting weaker demand for seasonal winter items such as snow tires and chains despite an unchanged number of weekends and national holidays compared with a year earlier. Offsetting some of this softness, the company noted solid performance in higher-value service categories, particularly safety inspection and maintenance and car purchase and sales, underscoring an ongoing shift in its revenue mix toward services even as product sales in weather-sensitive categories remain volatile.

The most recent analyst rating on (JP:9832) stock is a Buy with a Yen1776.00 price target. To see the full list of analyst forecasts on Autobacs Seven Co stock, see the JP:9832 Stock Forecast page.

Autobacs Seven Reports Sales Growth in October 2025

In October 2025, Autobacs Seven Co., Ltd. reported an increase in same-store and total-store sales by 3.0% and 4.1% respectively compared to the previous year. This growth was primarily driven by successful sales promotions in tires and strong demand for maintenance services, despite the number of weekends and holidays remaining unchanged from the previous year.

The most recent analyst rating on (JP:9832) stock is a Buy with a Yen1776.00 price target. To see the full list of analyst forecasts on Autobacs Seven Co stock, see the JP:9832 Stock Forecast page.